Vitamin K2 and biological aging: What the evidence says about arteries, bones, and longevity
Nutrition · Updated

Vitamin K2 and biological aging: What the evidence says about arteries, bones, and longevity

The Rotterdam Study linked higher vitamin K2 intake with lower coronary mortality, and a 2026 randomized trial found slower CAC progression with MK-7. Here is what K2 can and cannot prove for artery, bone, and longevity health.

#guide #faq #vitamin-k2 #longevity #aging #biomarkers #supplements #calcification #bones #heart

Clinically obvious vitamin K deficiency is rare in healthy adults, but standard clotting tests can still miss suboptimal activation of vitamin-K-dependent proteins such as MGP and osteocalcin — the proteins that help keep calcium in bones and out of arteries.

In 2004, the Rotterdam Study — one of the largest European cohort studies — followed 4,807 people for over 10 years and discovered that those who consumed the highest amounts of vitamin K2 had a 57% lower mortality from coronary heart disease and a 26% lower all-cause mortality. Not vitamin K1 (the one from green vegetables). K2 — the one almost nobody gets enough of.

Yet while everyone talks about vitamin D, omega-3, and magnesium, K2 remains in the shadows. It’s the most underestimated nutrient in longevity science.

What you’ll learn:


What Is Vitamin K2 and Why Is It Different From K1?

Vitamin K is a family of fat-soluble molecules, but beneath this name hide two very different vitamins with almost opposite functions in the body.

Quick definition: Vitamin K2 (menaquinone) is a fat-soluble vitamin that activates proteins responsible for directing calcium toward bones and away from arteries — a fundamental mechanism to prevent vascular aging and maintain skeletal health.

K1 vs. K2: Two Vitamins, Two Destinies

Characteristic Vitamin K1 (phylloquinone) Vitamin K2 (menaquinone)
Primary function Blood clotting Calcium distribution (bones vs. arteries)
Sources Leafy green vegetables (spinach, kale) Fermented foods (natto), aged cheeses, eggs
Absorption 5-10% from food Much higher (especially MK-7)
Half-life 1-2 hours 72 hours (MK-7)
Deficiency Clinically obvious deficiency is rare in Western countries Functional insufficiency can be missed by clotting tests
Effect on longevity Minimal (beyond clotting) Significant (vascular, bone, cerebral)

The critical point: you can eat all the spinach you want and have sufficient K1 for clotting while still having suboptimal K2-dependent protein activation — the pathway that helps protect arteries from calcification.

MK-4 vs. MK-7: The Forms That Matter

K2 exists in different subforms, but two dominate the research:

Form Name Half-life Sources Typical dosage
MK-4 Menaquinone-4 1-2 hours Meats, eggs, dairy 15-45 mg/day
MK-7 Menaquinone-7 ~72 hours Natto, supplements 100-360 mcg/day

MK-7 is the preferred form for longevity: its 72-hour half-life means a single daily dose maintains stable levels, allowing constant activation of anti-calcification proteins.


The Triage Theory: Why Your Body Steals K2 From Longevity

To understand why low functional vitamin K status can be invisible in routine care, you need to grasp a revolutionary concept proposed by biochemist Bruce Ames.

Biological Triage

Ames’ triage theory proposes that when a nutrient is scarce, the body distributes it with Darwinian logic: first for functions essential to immediate survival, then (if any remains) for long-term health.

For vitamin K, the hierarchy is clear:

  1. Priority 1 (survival): Blood clotting — without this, you’ll die from a cut
  2. Priority 2 (longevity): MGP protein activation (protects arteries from calcification)
  3. Priority 3 (longevity): Osteocalcin activation (directs calcium toward bones)
  4. Priority 4 (longevity): Brain functions (sphingolipid synthesis, Gas6 protein)

The Silent Theft

Here’s the problem: standard blood tests only measure clotting. If your prothrombin time is normal, the doctor will tell you “you’re fine.” But your body might have stolen all the K2 for clotting, leaving your arteries and bones unprotected.

The result: A normal clotting test does not prove that MGP and osteocalcin are fully activated. High levels of inactive MGP or uncarboxylated osteocalcin can signal functional vitamin K insufficiency even when classic bleeding-type deficiency is absent.

This explains the “calcium paradox”: calcium supplementation for bones can worsen arterial calcification if there isn’t enough K2 to direct that calcium to the right place.


The Science: How K2 Slows Biological Aging

Biological Age vs. Chronological Age

Your chronological age is how many years have passed since birth. Your biological age measures how fast your cells are actually aging.

Two people aged 55 can have radically different biological ages. One key variable? The state of their arteries. Arterial calcification — the process that K2 counteracts — is one of the main accelerators of biological aging.

The Calcium Score as an Indicator of Vascular Age

The Coronary Artery Calcium (CAC) score directly measures calcium deposited in coronary arteries. It’s one of the best predictors of cardiovascular risk and functions as a direct measure of your “vascular age.”

CAC Score Risk Vascular age offset
0 Minimal Your arteries are younger than your age
1-100 Mild +5-10 years of vascular age
101-400 Moderate +10-20 years of vascular age
>400 High +20-30 years of vascular age

Vitamin K2 is the main biological regulator of this process. By activating Matrix Gla protein (MGP), K2 prevents calcium from depositing in arterial walls — keeping your arteries elastic and “young.”

The Major Epidemiological Studies

Rotterdam Study (2004): 4,807 participants followed for 10+ years. Those who consumed more K2 showed:

  • 57% lower coronary heart disease mortality
  • 26% lower all-cause mortality
  • 52% lower severe aortic calcification
  • Every additional 10 mcg of K2 → 9% lower coronary risk

MESA Study + Danish study: Independent confirmations of the association between K2 intake and reduced calcification and cardiovascular events.

Dutch MK-7 trial (3 years): 180 mcg of MK-7 daily arrested the progression of arterial stiffness in postmenopausal women, while the placebo group continued to worsen.

VitaK-CAC trial (published in JAMA Cardiology, 2026): In 180 adults with symptomatic coronary artery disease, 2 years of MK-7 supplementation significantly attenuated coronary artery calcium progression compared with placebo. This is direct human evidence that vitamin K2 can influence calcification trajectory, but the authors still call for larger trials with hard clinical outcomes before treating MK-7 as proven cardiovascular prevention.


5 Anti-Aging Mechanisms of Vitamin K2

1. Arterial Decalcification: Rejuvenating Arteries

Arterial calcification is not an irreversible process. K2 activates Matrix Gla Protein (MGP) — the most potent inhibitor of soft tissue calcification known.

What the research says: Preclinical studies have shown that K2 can reduce arterial calcification by 50% in just 6 weeks. In humans, the 3-year Dutch trial with MK-7 demonstrated arrested progression of arterial stiffness.

How it works: K2 converts MGP from the inactive form (ucMGP) to the active form (cMGP) through a carboxylation reaction. Active MGP binds calcium in arterial walls and prevents its deposition — functioning as a molecular “vacuum cleaner” for misplaced calcium.

2. Bone Protection: Calcium Where It’s Really Needed

K2 doesn’t just remove calcium from arteries — it actively directs it toward bones through activation of osteocalcin, the second vitamin K-dependent protein.

What the research says: In Japan, where natto consumption is high, studies have shown that K2 (MK-4 at 45 mg/day) reduces vertebral fractures by 80% in women with osteoporosis. Osteocalcin activated by K2 is one of the main mediators of bone mineralization.

How it works: Osteocalcin, once activated by K2, binds to hydroxyapatite crystals in bone tissue, incorporating calcium into the bone’s mineral matrix. Without K2, osteocalcin remains inactive and the calcium you consume (or that vitamin D helps you absorb) has no guide to reach bones.

3. Neuroprotection: Sphingolipids and the Aging Brain

K2 plays a role in the brain that only recently has research begun to understand.

What the research says: A 2024 study published in Frontiers in Aging Neuroscience identified a direct link between K2-mediated vascular health and cognitive decline. K2 is necessary for the synthesis of sphingolipids — lipids fundamental to nerve cell membranes — and for the expression of Gas6 protein, which protects neurons from cell death.

How it works: K2 supports the brain through three pathways: (1) maintains cerebral vascular health by preventing calcification of microvessels, (2) enables synthesis of sphingolipids (sulfatides, cerebrosides) essential for myelin and synaptic function, (3) activates Gas6, a protein that inhibits neuronal apoptosis. Reduced sphingolipid levels are associated with Alzheimer’s and cognitive decline.

4. Anti-Inflammatory Action: Turning Off Inflammaging

Inflammaging — chronic low-grade inflammation associated with aging — is one of the main drivers of biological aging. K2 has anti-inflammatory power that goes far beyond what you’d expect from a vitamin.

What the research says: In vitro studies have shown that K2 has an antioxidant potential 10-100 times greater than K1. Additionally, K2 activates the NRF2/Keap-1 pathway, the main cellular defense system against oxidative stress, and inhibits the NF-κB pathway, the “master” of chronic inflammation.

How it works: K2 acts as a double switch: it turns on antioxidant defenses (NRF2) and turns off the inflammatory cascade (NF-κB). This reduces production of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6) and inflammatory markers like CRP (C-reactive protein) — one of the 9 biomarkers used to calculate biological age with PhenoAge.

5. Skin and Elasticity: K2 as Visible Anti-Aging

K2 doesn’t just protect what you can’t see (arteries, bones, brain) — it has measurable effects on skin aging too.

What the research says: A clinical study showed that 45 mcg of MK-7 daily for 12 weeks significantly improved skin elasticity and reduced wrinkle depth. The mechanism is linked to type I collagen production and extracellular matrix protection.

How it works: Calcification doesn’t just affect arteries — skin also accumulates calcium microdeposits with age, contributing to loss of elasticity. K2 prevents this ectopic calcification and supports collagen production, the main structural component of skin.


Optimal Dosages for Longevity

Research provides clear guidance, but it’s important to distinguish the different forms:

MK-7 (menaquinone-7) — The Preferred Form for Longevity

Goal MK-7 dosage Scientific basis
General health 100-200 mcg/day International recommendations
Arterial protection 180-360 mcg/day 3-year Dutch trial
Skin anti-aging 45+ mcg/day 12-week clinical study
Maximum studied dose 360 mcg/day No adverse effects reported

MK-4 (menaquinone-4) — The Form for Bone Health

Goal MK-4 dosage Scientific basis
Fracture prevention 45 mg/day Japanese protocol (split into 3 doses)

Important note: 45 mg (milligrams) of MK-4 is a much higher dosage than 360 mcg (micrograms) of MK-7. The two forms are not interchangeable due to different half-life and bioavailability.

Timelines: When to Expect Results

  • 2-4 weeks: first effects on MGP carboxylation
  • 8-12 weeks: measurable improvements in skin elasticity
  • 6-12 months: effects on arterial stiffness
  • 1-3 years: slowing of CAC score progression

The information provided does not replace professional medical advice. Consult your doctor before starting any supplementation.


Best Sources: Food vs. Supplements

Food Sources of Vitamin K2

Food sources provide K2 along with other nutrients — proteins, fats, minerals — that improve absorption (being fat-soluble, K2 is better absorbed with fats).

Food K2 per 100g (3.5 oz) Predominant form Note
Natto (fermented soybeans) ~1,100 mcg MK-7 The richest source by far
Gouda ~75 mcg MK-7 + MK-9 Aged cheeses have more K2
Brie ~50 mcg MK-7 Soft-ripened cheeses
Goose liver ~370 mcg MK-4 Rich but limited consumption
Egg yolk ~30 mcg MK-4 Free-range: up to 3x more
Chicken (dark meat) ~60 mcg MK-4 Dark meat > white meat
Butter (grass-fed) ~15 mcg MK-4 Varies with season

The problem: Unless you consume natto regularly (common in Japan but rare in the West), it’s very difficult to reach dosages of 180+ mcg of MK-7 daily from food sources alone.

When Supplements Make Sense

For most Westerners, K2 supplementation is reasonable — especially if you:

  • Don’t consume natto regularly
  • Take vitamin D3 (K2 is its natural partner)
  • Take calcium supplements (risk of calcification without K2)
  • Are over 50 years old (deficiency worsens with age)
  • Have family history of cardiovascular disease

How to choose:

  • Look for MK-7 form for long-term longevity benefits
  • Ensure it’s in trans form (the biologically active form)
  • Take with a meal containing fats to maximize absorption
  • Look for third-party tested products for purity and potency

The Longevity Stack: K2 + D3 + Calcium

If there’s one synergy in longevity nutrition that needs to be understood, it’s this. Vitamin K2 and vitamin D3 aren’t optional for each other — they’re biological partners.

Why D3 Without K2 Can Be a Problem

Vitamin D3 increases calcium absorption from the intestine — that’s its main role. But once calcium is in the blood, who decides where it goes? The answer is K2.

Without sufficient K2:

  • Calcium absorbed thanks to D3 can deposit in arteries
  • Calcium supplementation for bones can paradoxically increase cardiovascular risk
  • Studies have shown that high-dose D3 without K2 can accelerate arterial calcification

With sufficient K2:

  • Calcium is directed toward bones (activated osteocalcin)
  • Arteries are protected from calcification (activated MGP)
  • D3+K2 synergy reduces arterial stiffness

The Complete Longevity Stack

Combining data from the DO-HEALTH trial on omega-3 with research on D3+K2 synergy:

Intervention Dosage Role in stack
Vitamin D3 2,000 IU/day Calcium absorption, immunity, 2.6-year biological age reduction
Vitamin K2 (MK-7) 180-200 mcg/day Directs calcium, protects arteries and bones
Omega-3 (EPA+DHA) 1,000 mg/day Anti-inflammatory, slows epigenetic clocks by 3.8 months
Magnesium 300-400 mg/day Cofactor for D3 and K2, 300+ enzymatic reactions
Physical exercise 150 min/week moderate VO2 max, insulin sensitivity, autophagy

This is an evidence-based, accessible, and affordable stack. Each component amplifies the effect of the others.


How to Monitor K2 Optimization

Unlike other nutrients, blood level of vitamin K2 is not a routine test. But there are indirect — and very informative — ways to assess whether your K2 is doing its job.

Key Biomarkers

Biomarker What it measures Optimal level How it relates to K2
dp-ucMGP Inactive (uncarboxylated) MGP <500 pmol/L High levels = functional K2 deficiency
Uncarboxylated osteocalcin Bone activation of K2 Low High levels = insufficient K2 for bones
CAC score Coronary calcification 0 Direct measure of damage K2 prevents
CRP Systemic inflammation <1 mg/L K2 reduces inflammation via NF-κB
Alkaline phosphatase (ALP) Bone metabolism 44-147 U/L Indicator of bone turnover influenced by K2
Homocysteine Cardiovascular risk <10 μmol/L K2 works synergistically with B vitamins

The Practical Approach

Even without specific tests for K2, you can monitor downstream markers that K2 influences:


How SuperAge Tracks Your Biological Age

Vitamin K2 directly influences cardiovascular health — and cardiovascular health is the highest-weighted factor in biological age calculation.

The Weight of Cardiovascular Health

SuperAge calculates your biological age using data from your Apple Watch, where the cardiovascular domain represents the most important component of the algorithm. This includes HRV, resting heart rate, VO2 max, and stress level — all parameters that arterial health directly influences.

Elastic, non-calcified arteries mean:

  • Better VO2 max (flexible arteries transport oxygen more efficiently)
  • Lower resting heart rate (less vascular resistance)
  • Higher HRV (better autonomic function)

From Blood Analysis to Your Wrist

SuperAge tracks 64 blood biomarkers, including markers directly influenced by K2:

  • CRP — K2’s anti-inflammatory action (NRF2/NF-κB) reduces this key PhenoAge marker
  • ALP (alkaline phosphatase) — Reflects bone metabolism regulated by K2
  • Calcium — The mineral K2 directs toward bones
  • Vitamin D — K2’s synergistic partner
  • Glucose and HbA1c — K2 improves insulin sensitivity

You can scan your blood tests with the camera or import a PDF, and the app automatically extracts values via artificial intelligence — making it easy to monitor how K2 supplementation influences your biomarkers over time.

Ready to measure your progress? Download SuperAge and start tracking your biological age along with your biomarkers.


Important Warnings

Interaction with Anticoagulants

Those taking warfarin or other vitamin K antagonists must consult their doctor before taking K2. Vitamin K (in any form) can interfere with warfarin’s anticoagulant effect. However, it’s important to know that:

  • K2 (especially MK-7) has a much lower effect on clotting than K1
  • Some studies suggest that stable doses of K2 may actually stabilize INR in patients on warfarin therapy
  • New oral anticoagulants (DOACs) like rivaroxaban and apixaban do not interact with vitamin K

General Safety

  • No K2 toxicity has been observed even at high doses (up to 360 mcg MK-7/day for 3 years)
  • No significant side effects are known at recommended doses
  • K2 has no contraindications in patients with chronic kidney disease (in fact, it may be particularly beneficial for vascular calcification associated with CKD)

Frequently Asked Questions

What is vitamin K2 and what is it used for?

Vitamin K2 (menaquinone) is a fat-soluble vitamin that activates two fundamental proteins: Matrix Gla Protein (MGP), which prevents calcium from depositing in arteries, and osteocalcin, which directs calcium toward bones. In summary, K2 is the “traffic controller” of calcium in your body — a crucial role for cardiovascular and bone health as you age.

What’s the difference between vitamin K1 and K2?

K1 (phylloquinone) is found in green vegetables and serves primarily for blood clotting. K2 (menaquinone) is found in fermented foods and animal products and supports calcium distribution, arterial protection, and bone health. You can have sufficient K1 for clotting while still having suboptimal K2-dependent protein activation, because the forms have different sources, tissue distribution, and half-lives.

How much vitamin K2 should I take per day?

For general health, research suggests 100-200 mcg of MK-7 daily. For optimal cardiovascular protection, clinical trials have used 180-360 mcg of MK-7 daily. The MK-7 form is preferred for longevity due to its 72-hour half-life. Always consult your doctor before starting any supplementation.

Can K2 really reverse arterial calcification?

Preclinical studies have shown calcification reductions up to 50% in 6 weeks. In humans, the 3-year Dutch trial showed that 180 mcg of MK-7 daily arrested the progression of arterial stiffness. Complete reversal of calcification hasn’t yet been demonstrated in human studies, but slowing and arrest have been.

Should I take K2 if I take vitamin D?

Yes, it’s strongly recommended. Vitamin D increases calcium absorption, but without sufficient K2 that calcium can deposit in arteries. K2 activates proteins that direct calcium toward bones and away from soft tissues. Many experts consider D3 and K2 inseparable supplementation.

What are the symptoms of K2 deficiency?

Low functional K2 status is usually “silent” — it does not cause the acute bleeding signs clinicians associate with severe vitamin K deficiency. Over the long term, inadequate activation of MGP and osteocalcin may contribute to arterial calcification risk and poorer bone mineralization. Standard clotting tests do not detect this well; specialized markers such as dp-ucMGP or uncarboxylated osteocalcin are more informative.

Does K2 interfere with anticoagulants?

K2 (MK-7) has a lower effect on clotting than K1, but those taking warfarin must consult their doctor before supplementing it, as vitamin K can reduce the anticoagulant’s efficacy. New oral anticoagulants (DOACs like rivaroxaban and apixaban) do not interact with vitamin K.

How long does it take to see K2 benefits?

MGP carboxylation begins within 2-4 weeks. Improvements in skin elasticity have been measured in 12 weeks. Effects on arterial stiffness require 6-12 months. Slowing CAC score progression requires 1-3 years. K2 is a long-term intervention, not a quick fix.


Key Points

  • 57% lower coronary mortality was observed in the Rotterdam Study in people with highest K2 intake
  • Normal clotting tests do not rule out functional vitamin K insufficiency in MGP and osteocalcin pathways
  • K2 is the “traffic controller” of calcium: it removes it from arteries (MGP) and directs it toward bones (osteocalcin)
  • The triage theory explains why: your body steals K2 from longevity to ensure survival (clotting)
  • 5 anti-aging mechanisms: arterial protection, bone health, neuroprotection, anti-inflammatory action, skin elasticity
  • 180 mcg of MK-7 daily improved arterial-stiffness markers in postmenopausal women, and a 2026 trial found slower CAC progression in adults with coronary artery disease
  • The D3 + K2 stack is inseparable: D3 increases calcium in blood, K2 decides where it goes
  • Natto is the richest source (1,100 mcg/100g), but supplementation is often necessary in the West

Start Measuring Your Longevity Journey

Vitamin K2 is probably the most underestimated nutrient in longevity science. It protects your arteries from calcification, keeps bones strong, supports the brain, and fights chronic inflammation — all with minimal dosage and virtually no side effects.

But like any health intervention, it works best if you can measure its impact. Tracking your biological age and biomarkers over time lets you see if the changes you’re making — from K2, to vitamin D, to omega-3, to physical exercise — are actually working.

Ready to take control? Download SuperAge and start tracking your biological age along with your longevity interventions.


References

  1. Geleijnse JM et al. Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the Rotterdam Study — Journal of Nutrition, 2004
  2. Knapen MHJ et al. Menaquinone-7 supplementation improves arterial stiffness in healthy postmenopausal women: a double-blind randomised clinical trial — Thrombosis and Haemostasis, 2015
  3. Simes DC et al. Vitamin K as a powerful micronutrient in aging and age-related diseases: pros and cons from clinical studies — International Journal of Molecular Sciences, 2019
  4. Alisi L et al. The protective role of vitamin K in aging and age-related diseases — Nutrients, 2024
  5. Schurgers LJ et al. The role of vitamin K and vitamin K-dependent proteins in vascular calcification — Zeitschrift für Kardiologie, 2001
  6. Vermeer C. Vitamin K: the effect on health beyond coagulation — an overview — Food & Nutrition Research, 2012
  7. Beulens JW et al. High dietary menaquinone intake is associated with reduced coronary calcification — Atherosclerosis, 2009
  8. Popa DS et al. The role of vitamin K2 in cognitive impairment: linking vascular health to brain health — Frontiers in Aging Neuroscience, 2024
  9. Halder M et al. Vitamin K: double bonds beyond coagulation — insights into differences between vitamin K1 and K2 in health and disease — International Journal of Molecular Sciences, 2019
  10. Schurgers LJ et al. Two Years of Menaquinone-7 Supplementation and Coronary Artery Calcification: A Randomized Clinical TrialJAMA Cardiology, 2026.
  11. Effects of One-Year Menaquinone-7 Supplementation on Vascular Stiffness and Blood Pressure in Pre-, Peri-, and Post-Menopausal Women (2025).

Last updated: 2026-06-26. This article is regularly reviewed to ensure accuracy.

The information provided in this article does not replace professional medical advice. Consult your doctor before starting any dietary supplementation.

Written by SuperAge Team

The SuperAge Team writes evidence-informed guides on biological age, longevity biomarkers, Apple Health, wearables, and practical healthspan tracking.